Certain drugs on the formulary are classified as 'amber' which means they are suitable for shared care prescribing under agreed shared care guidance.
Shared Care Guidance is available for specific drugs where therapy is initiated in the specialist setting but, at an agreed time, prescribing and drug monitoring is taken over by primary care. Shared care agreements have clearly defined areas of responsibility.
The existence of a shared care agreement does not imply that patients will automatically be accepted for shared care. It should be considered on a case-by-case basis for stabilised patients only. A GP has the right to decline shared care on clinical grounds or if he or she does not feel confident in managing the drug or condition.
If you are unable to accept shared care then you should complete this form and send to initiating organisation declining prescribing.
In such cases, you are encouraged to discuss your concerns with the referring consultant and/or the Medicines Management team to explore whether they can be safely resolved.
Please note that if you are requested to prescribe Melatonin by Sussex Partnership NHS Foundation Trust, please contact the Medicines Management Team with the details
Information Sheets for ‘blue’ drugs (which should be initiated by a specialist) are also being developed to facilitate the transfer of prescribing responsibilities.
Specialist should send agreement to GP to request shared care.
Shared Care Agreements for Amber Drugs
Information Sheets for Blue Drugs
See individual drug entries for amber shared care and blue information sheets